You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

    Recruiting
    • Squamous Cell Carcinoma of Oral Cavity
    • +3 more
    • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
    • Gliwice, Silesia, Poland
      The Maria Sklodowska-Curie National Research Institute of Oncolo
    Aug 7, 2023

    Hepatocellular Carcinoma Trial in Yerevan

    Recruiting
    • Hepatocellular Carcinoma
      • Yerevan, Armenia
        Nikomed Medical Center
      Jun 28, 2023

      Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • +6 more
      • (no location specified)
      Aug 4, 2023

      Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Skin
      • +2 more
      • Marlborough, Massachusetts
        Phio Pharmaceuticals Corp.
      Aug 25, 2023

      Process for Hepatocellular Carcinoma

      Not yet recruiting
      • Hepatocellular Carcinoma
        • (no location specified)
        May 5, 2023

        Merkel Cell Carcinoma Clinical Trial Engagement Patterns

        Not yet recruiting
        • Merkel Cell Carcinoma
          • San Francisco, California
            Power Life Sciences
          Sep 8, 2023

          Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

          Not yet recruiting
          • Nasopharyngeal Carcinoma
          • KSD-101
          • Wuhan, China
            Tongji Hospital, Tongji Medical College, Huazhong University of
          Oct 19, 2023

          Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

          Not yet recruiting
          • Squamous Cell Carcinoma
            • San Francisco, California
              Power Life Sciences
            Jun 23, 2023

            Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

            Recruiting
            • Esophageal Squamous Cell Carcinoma
            • no intervention
            • Wuhan, Hubei, China
              Renmin hosptial of Wuhan University
            Jul 29, 2023

            Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

            Completed
            • Resectable Hepatocellular Carcinoma
            • Liver Resection
            • Jakarta Pusat, DKI Jakarta, Indonesia
              Dr. Cipto Mangunkusumo General Hospital
            Aug 24, 2023

            Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

            Recruiting
            • Nasopharyngeal Carcinoma
            • Endostar and Envafolimab
            • Hangzhou, Zhejiang, China
              Zhejiang Cancer Hospital
            Sep 24, 2023

            Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

            Recruiting
            • Nasopharyngeal Carcinoma
            • Hangzhou, Zhejiang, China
              Zhejiang Cancer Hospital
            Apr 2, 2023

            Delving Into Participation Trends in Renal Cell Carcinoma

            Not yet recruiting
            • Renal Cell Carcinoma
              • San Francisco, California
                Power Life Sciences
              Oct 16, 2023

              Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

              Not yet recruiting
              • Head and Neck Squamous Cell Carcinoma
              • PET/CT
              • Neck dissection
              • (no location specified)
              Jan 31, 2023

              Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

              Not yet recruiting
              • Locally Advanced Head and Neck Squamous Cell Carcinoma
              • (no location specified)
              Mar 20, 2023

              Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

              Recruiting
              • Unresectable Hepatocellular Carcinoma
              • Yttrium-90 carbon microspheres SIRT
              • Nanjing, China
                Gao-Jun Teng
              Jul 20, 2023

              Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

              Not yet recruiting
              • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
              • (no location specified)
              Mar 17, 2023

              Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

              Not yet recruiting
              • Cutaneous Squamous Cell Carcinoma
              • (no location specified)
              May 24, 2023

              Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

              Not yet recruiting
              • Squamous Cell Carcinoma of Head and Neck
              • Basal Cell Carcinoma of Skin
              • microscopy confocal (Histolog Scanner)
              • Vandœuvre-lès-Nancy, France
                Gilles Dolivet
              Jul 7, 2023

              Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)

              Not yet recruiting
              • Cirrhosis, Liver
              • Epigallocatechin gallate (EGCG)
              • Placebo
              • (no location specified)
              Aug 27, 2023

              Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

              Recruiting
              • Renal Cell Carcinoma
              • 68Ga-NY104 PET/CT
              • Beijing, Beijing, China
                Peking Union Medical College Hospital
              Jun 5, 2023

              Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

              Recruiting
              • Hepatocellular Carcinoma
              • Seoul, Korea, Republic of
                Asan Medical Center
              Nov 14, 2023

              Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC)

              Recruiting
              • Hepatocellular Carcinoma
              • Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC
              • Guangzhou, Guangdong, China
                Guangdong Provincial People's Hospital
              Jul 12, 2023

              Advanced Hepatocellular Carcinoma Trial (CD-801)

              Not yet recruiting
              • Advanced Hepatocellular Carcinoma
              • (no location specified)
              Oct 13, 2023